Log In
BCIQ
Print this Print this
 

Fexinidazole

  Manage Alerts
Collapse Summary General Information
Company Drugs for Neglected Diseases initiative (DNDi)
DescriptionOral antiprotozoal nitroimidazole
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationTrypanosome
Indication DetailsTreat human African trypanosomiasis (sleeping sickness)
Regulatory Designation
PartnerSanofi

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/25/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today